Table 1 Results of urine filtering examination 2010-2011
2010 | 2011 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
June | August | P value | June | August | P value | |||||||||||
Number of Subjects | Before 1st MDA | Number of Subjects | 8 weeks after 1st MDA | Number of Subjects | Before 2nd MDA | Number of Subjects | 8 weeks after 2nd MDA | |||||||||
Egg positive number | Egg positive prevalence (95% CI) | Egg positive number | Egg positive prevalence (95% CI) | Egg positive number | Egg positive prevelence (95% CI) | Egg positive number | Egg positive prevalence (95% CI) | |||||||||
Total | 242 | 83 | 34.3 (28.5-40.5) | 260 | 33 | 12.7** (9.2-17.3) | P<0.01 | 315 | 46 | 14.6 (11.1-19.0) | 350 | 24 | 6.9** (4.6-10.0) | P<0.01 | ||
Male | 108 | 46 | 42.6 (33.6-52.1) | 123 | 16 | 13.0** (8.1-20.2) | P<0.01 | 152 | 25 | 16.4 (11.4-23.2) | 172 | 9 | 5.2** (2.8-9.7) | P<0.01 | ||
Female | 134 | 37 | 27.6 (20.7-35.8) | 137 | 17 | 12.4 (8.3-20.0) | P<0.01 | 163 | 21 | 12.9 (8.5-19.0) | 178 | 15 | 8.4 (5.1-13.5) | P=0.181 | ||
Age group | 〜4 | Male | 5 | 3 | 60.0 (22.8-88.4) | 6 | 0 | 0.0* (0.0-39.5) | P<0.05 | 11 | 3 | 27.3 (9.6-56.8) | 12 | 1 | 8.3 (1.5-35.7) | P=0.231 |
Female | 4 | 0 | 0.0 (0.0-49.5) | 4 | 0 | 0.0 (0.0-49.5) | - | 4 | 1 | 25.0 (4.5-70.3) | 6 | 1 | 16.7 (3.0-56.7) | P=0.322 | ||
Total | 9 | 3 | 33.3 (11.9-64.8) | 10 | 0 | 0.0* (0.0-28.2) | P<0.05 | 15 | 4 | 26.7 (10.8-52.2) | 18 | 2 | 11.1 (3.1-33.1) | P=0.249 | ||
5〜9 | Male | 25 | 8 | 32.1 (17.1-51.8) | 26 | 0 | 0.0 (0.0-13.1) | P<0.01 | 31 | 5 | 16.1 (7.0-32.8) | 32 | 2 | 6.3 (1.7-20.3) | P=0.212 | |
Female | 29 | 10 | 34.5 (19.8-52.8) | 30 | 2 | 6.7** (1.7-20.3) | P<0.01 | 29 | 6 | 20.7 (9.8-38.6) | 27 | 5 | 18.5 (8.1-36.9) | P=0.838 | ||
Total | 54 | 18 | 33.4 (22.1-46.8) | 56 | 2 | 3.6** (1.0-12.2) | P<0.h01 | 60 | 11 | 18.3 (10.5-30.1) | 59 | 7 | 11.9 (5.8-22.7) | P=0.325 | ||
10〜14 | Male | 22 | 11 | 50 (30.6-69.4) | 24 | 3 | 12.5** (4.3-31.2) | P<0.01 | 24 | 8 | 33.3 (17.9-53.5) | 21 | 3 | 14.3 (4.9-34.9) | P=0.138 | |
Female | 26 | 7 | 26.9 (13.6-46.3) | 26 | 5 | 19.2 (8.4-38.1) | P=0.510 | 28 | 7 | 25.0 (12.6-43.6) | 32 | 2 | 6.3* (1.7-20.3) | P<0.05 | ||
Total | 48 | 18 | 37.5 (25.1-51.8) | 50 | 8 | 16.0* (8.3-28.7) | P<0.05 | 52 | 15 | 28.8 (18.2-42.4) | 53 | 5 | 9.4* (4.1-20.4) | P<0.05 | ||
15〜19 | Male | 11 | 5 | 45.5 (21.1-72.2) | 14 | 3 | 21.4 (7.5-47.9) | P=0.201 | 14 | 2 | 14.3 (4.0-40.2) | 17 | 0 | 0.0 (0.0-18.7) | P=0.107 | |
Female | 10 | 3 | 30.0 (10.7-60.6) | 14 | 3 | 21.4 (7.5-47.9) | P=0.632 | 14 | 4 | 28.6 (11.6-54.9) | 14 | 1 | 7.1 (1.3-31.8) | P=0.139 | ||
Total | 21 | 8 | 38.1 (20.6-59.3) | 28 | 6 | 21.4 (10.1-39.7) | P=0.201 | 28 | 6 | 21.4 (10.1-39.7) | 31 | 1 | 3.2* (0.6-16.4) | P<0.05 | ||
20〜29 | Male | 15 | 8 | 53.3 (29.9-75.4) | 19 | 4 | 21.1 (8.4-43.6) | P=0.051 | 21 | 2 | 9.5 (2.6-29.2) | 23 | 2 | 8.7 (2.4-27.0) | P=0.924 | |
Female | 25 | 11 | 44.0 (26.5-63.1) | 27 | 3 | 11.1** (3.8-28.3) | P<0.01 | 30 | 1 | 3.3 (0.6-16.9) | 29 | 2 | 6.9 (1.9-22.2) | P=0.533 | ||
Total | 40 | 19 | 47.5 (32.8-62.6) | 46 | 7 | 15.2 (7.5-28.4) | P<0.01 | 51 | 3 | 5.9 (2.0-16.1) | 52 | 4 | 7.7 (3.0-18.3) | P=0.715 | ||
30〜39 | Male | 14 | 5 | 35.7 (16.2-61.5) | 16 | 4 | 25.0 (10.1-49.7) | P=0.523 | 16 | 2 | 12.5 (3.5-36.3) | 18 | 1 | 5.6 (1.0-26.0) | P=0.476 | |
Female | 15 | 5 | 33.3 (15.1-58.5) | 18 | 1 | 5.6* (1.0-26.0) | P<0.05 | 18 | 1 | 5.6 (1.0-26.0) | 18 | 2 | 11.1 (3.1-33.1) | P=0.546 | ||
Total | 29 | 10 | 34.5 (19.8-52.8) | 34 | 5 | 14.7 (6.4-30.3) | P=0.066 | 34 | 3 | 8.8 (3.0-23.1) | 36 | 3 | 8.3 (2.8-22.0) | P=0.942 | ||
40〜 | Male | 16 | 6 | 37.5 (18.3-61.6) | 18 | 2 | 11.1 (3.1-33.1) | P=0.070 | 24 | 3 | 12.5 (4.3-31.2) | 25 | 0 | 0.0 (0.0-13.6) | P=0.068 | |
Female | 25 | 1 | 4.0 (0.7-19.8) | 18 | 3 | 16.7 (5.8-39.5) | P=0.158 | 29 | 1 | 3.4 (0.6-17.4) | 27 | 2 | 7.4 (2.0-23.6) | P=0.511 | ||
Total | 41 | 7 | 17.1 (8.5-31.4) | 36 | 5 | 13.9 (6.0-28.8) | P=0.701 | 53 | 4 | 7.5 (2.9-18.0) | 52 | 2 | 3.8 (1.0-13.1) | P=0.414 | ||